CYTORA Showcases Neurodegenerative Pipeline at SACHS Neuroscience Innovation Forum in San Francisco

11 January 2026

CYTORA’s CEO Dr Yona Geffen was pleased to contribute to the 9th Annual SACHS Neuroscience Innovation Forum at the Marines’ Memorial Club, San Francisco on the 11th of January 2026. The NIF is an event renowned for connecting high-level keynotes with the latest advances in neurotech and diagnostics.

Positioned at the beginning of JPM week, the NIF forum focuses on the latest developments across key areas of neuroscience, which are currently attracting record investor interest and deal flow. Dr. Yona Geffen addressed an audience of specialized investors and clinicians, centered on CYTORA's unique position as a clinical-stage biopharmaceutical company leveraging human oral mucosal stem cells to address the complexities of Multiple System Atrophy, Parkinson’s Disease, and other Neurological diseases.